Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials. Lancet - Brightling, C E; Gaga, M; Inoue, H (Respir Med, 2020)
et al.